Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice-Reference-Cited by-同舟云学术

Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice

Published:2020 Issue:3 Volume:34 Page:1037-1045
ISSN:0258-851X
Container-title:In Vivo
language:en
Short-container-title:In Vivo

Author:

KANOU SHUNSUKE,MIYASHITA TOMOHARU,YAMAMOTO YASUHIKO,TAKADA SATOSHI,NAKURA MAKOTO,OKAZAKI MITSUYOSHI,OHBATAKE YOSHINAO,NAKANUMA SHINICHI,MAKINO ISAMU,TAJIMA HIDEHIRO,TAKAMURA HIROYUKI,FUSHIDA SACHIO,OHTA TETSUO

Publisher

Anticancer Research USA Inc.

Subject

Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assaying ADAMTS13 Activity as a Potential Prognostic Biomarker for Sinusoidal Obstruction Syndrome in Mice;International Journal of Molecular Sciences;2023-11-15

2. Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development;Frontiers in Immunology;2022-11-21

3. Thrombopoietin accumulation in hepatocytes induces a decrease in its serum levels in a sinusoidal obstruction syndrome model;Molecular Medicine Reports;2022-04-26

4. Efficacy and safety of recombinant thrombomodulin for the prophylaxis of veno-occlusive complication in allogeneiccit hematopoietic stem cell transplantation: A systematic review and meta-analysis;Hematology/Oncology and Stem Cell Therapy;2021-10

5. Platelets prevent the development of monocrotaline-induced liver injury in mice;Toxicology Letters;2020-12